- SeaSpine Holdings Corporation SPNE received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH Navigation System.
- The approval expands the applications and functionality of the FLASH Navigation System for cranial surgery and minimally invasive spine surgery for the European market.
- The 7D FLASH Navigation System uses visible light to quickly create a three-dimensional image for surgical navigation, resulting in shorter and more efficient spinal and cranial procedures.
- Also Read: SeaSpine Warns Surgical Revenue To Be Hit By COVID-19.
- Related content: Benzinga's Full FDA Calendar.
- Price Action: SPNE stock closed at $15.25 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
